- Filed
- Feb 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 25, 2025 | 78.6M sh |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $71.72M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $70.75M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $418.53M |
| Current Assets | FY 2024 · Dec 31, 2023 | $341.99M |
| Total Assets | FY 2024 · Dec 31, 2023 | $444.06M |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 73.23M sh |
| Capex | FY 2024 · Dec 31, 2022 | $5.2M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$89.36M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$1.91 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$1.91 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $69.44M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $88.25M |
| Net Income | FY 2024 · Dec 31, 2022 | −$139.92M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$140.57M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $209.1M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $69.98M |
| Revenue | FY 2024 · Dec 31, 2022 | $279.08M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $138.29M |